COVID-19 RNA Based Vaccines and the Risk of Prion Disease

Vaccines have been found to cause a host of chronic, late developing adverse events. Some adverse events like type 1 diabetes may not occur until 3-4 years after a vaccine is administered.

COVID-19 RNA Based Vaccines and the Risk of Prion Disease

The advent of new vaccine technology creates new potential mechanisms of vaccine adverse events.

RNA based vaccines offers special risks of inducing specific adverse events. One such potential adverse event is prion based diseases caused by activation of intrinsic proteins to form prions. A wealth of knowledge has been published on a class of RNA binding proteins shown to participating in causing a number of neurological diseases including Alzheimer’s disease and ALS.

The Pfizer RNA based COVID-19 vaccine was approved by the US FDA under an emergency use authorization without long term safety data. Because of concerns about the safety of this vaccine a study was performed to determine if the vaccine could potentially induce prion based disease.

There is an old saying in medicine that “the cure may be worse than the disease.” The phrase can be applied to vaccines.

Over the last two decades there has been a concern among certain scientists that prions could be used as bioweapons.

Pfizer’s RNA based COVID-19 vaccine contains RNA sequences that have been shown to have the potential to induce chronic degenerative neurological diseases, including Alzheimer’s, ALS and other neurodegenerative diseases, such as Creutzfeldt-Jakob disease.

 

Leave a Reply